|
| 1 |
Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer
Masaya Uno, Rie Matsuo, Naoki Maezawa, Tomoyasu Kato
Obstet Gynecol Sci.2023;66(4):290-299. Published online 2023 July 15
DOI: http://dx.doi.org/10.5468/ogs.23024
|
|
| 2 |
Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study
Se Ik Kim, Hyunji Lim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Maria Lee
Cancer Res Treat.2023;55(1):245-257. Published online 2022 July 19
DOI: http://dx.doi.org/10.4143/crt.2022.232
|
|
| 3 |
Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of Chemotherapy
Aeran Seol, Ga Won Yim, Joo Yeon Chung, Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong Sang Song
Cancer Res Treat.2022;54(4):1219-1229. Published online 2021 November 17
DOI: http://dx.doi.org/10.4143/crt.2021.1010
|
|
| 4 |
Disparities between Uptake of Germline BRCA1/2 Gene Tests and Implementation of Post-test Management Strategies in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Young Min Hur, Jaehee Mun, Mi-Kyung Kim, Maria Lee, Yun Hwan Kim, Seung-Cheol Kim
|
|
| 5 |
Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry
Hyeong In Ha, Eun-Gyeong Lee, Jiwon Lim, So-Youn Jung, Yoon Jung Chang, Young-Joo Won, Myong Cheol Lim
Cancer Res Treat.2021;53(2):541-548. Published online 2020 November 18
DOI: http://dx.doi.org/10.4143/crt.2020.1001
|
|
| 6 |
A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer
Junsik Park, Kyung Jin Eoh, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim, Jung-Yun Lee
Yonsei Med J.2020;61(4):284-290. Published online 2020 March 25
DOI: http://dx.doi.org/10.3349/ymj.2020.61.4.284
|
|
| 7 |
Efficacy and safety of neoadjuvant chemotherapy versus primary debulking surgery in patients with ovarian cancer: a meta-analysis
Xiaofeng Lv, Shihong Cui, Xiao'an Zhang, Chenchen Ren
|
|
| 8 |
Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving
De-Ying Wang, Na Li, Yu-Lan Cui
Cancer Res Treat.2020;52(3):798-814. Published online 2020 March 3
DOI: http://dx.doi.org/10.4143/crt.2019.498
|
|
| 9 |
Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma
Min Chul Choi, Sohyun Hwang, Sewha Kim, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Tae-Heon Kim, Haeyoun Kang, Hee Jung An
Cancer Res Treat.2020;52(2):634-644. Published online 2020 January 6
DOI: http://dx.doi.org/10.4143/crt.2019.207
|
|
| 10 |
Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer
Emre Günakan, Yusuf Aytaç Tohma, Mehmet Tunç, Hüseyin Akıllı, Hanifi Şahin, Ali Ayhan
|
|
| 11 |
Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea
Jun Hyeong Seo, Soo Young Jeong, Myeong Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi
|
|
| 12 |
A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D
Jung-Yun Lee, Jae Weon Kim, Myong Cheol Lim, Sunghoon Kim, Hee Seung Kim, Chel Hun Choi, Ju Yeon Yi, Sang-Yoon Park, Byoung-Gie Kim,
|
|
| 13 |
Efficacy and safety of neoadjuvant chemotherapy versus primary debulking surgery in patients with ovarian cancer: a meta-analysis
Xiaofeng Lv, Shihong Cui, Xiao'an Zhang, Chenchen Ren
|
|
| 14 |
Malignant Gynecologic Tomors in Childhood and Adolescence : Clinicopathologic Review of 29 Cases in SNUH
Ju Won Roh, Moon Hong Kim, Sung Il Kim, Ji Young Lee, Jeong Hwa Kim, Jae Weon Kim, Noh Hyun Park, Yong Sang Song, Soon Beom Kang, Hyo Pyo Lee
|
|
| 15 |
Proliferating Cell Nuclear Antigen : Relation to Histologic Grade and Prognosis
Seung Hwa Shin, Eun Dong Park
|
|
| 16 |
Multivariable Analysis of Glutathione S-Transferase-pi, P-glycoprotein, and Metallothionein as Indicator of Resistance to Chemotherapy in Epithelial Ovarian Cancer
KT Kim, DS Nah, YY Hwang, MH Park, SY Lee, SW Lee
|
|
| 17 |
Clinical Significance of DNA Ploidy in Epithelial Ovarian Malignancy
Byung Young Lee, Hyun Chan Kim
|
|
| 18 |
Significance of Thrombocytosis in Patients with Epithelial Ovarian Cancer
Jong Hyeok Kim, Jin Seok Jung, Chang won Koh, Jun Hee Na, Yong Man Kim, Young Tak Kim, Joo Hyun Nam, Jung Eun Mok
|
|
| 19 |
Quantitative Pathologic Variables as Prognostic Factors in Epithelial Ovarian Cancer
Jong Hyeok Kim, Jooryung Huh, Chang Won Koh, Jun Hee Na, Bong Hee Kim, Yong Man Kim, Young Tak Kim, Joo Hyun Nam, Jung Eun Mok
|
|
| 20 |
Expression of Urokinase-type Plasminogen Activator(uRA), Plasminogen Activator Inhibitor-1(PAI-1) and nm23 protein, as Prognostic Factors in Epithelial Ovarian Cancer
Kyung Tai Kim, Ho Sang Seo, Ki Heon Lee, Young Jin Moon, Sam Hyun Cho, Hyung Moon, Wan Sub Kim, Moon Hyang Park, Youn Yeoung Hwang
|
|
